7-(2-methyl-1H-benzimidazol-6-yl)-4-(6-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)-2,3,4,5-tetrahydro-1,4-benzoxazepine | 1256945-99-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶嗪类
• 英文名称: 7-(2-methyl-1H-benzimidazol-6-yl)-4-(6-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)-2,3,4,5-tetrahydro-1,4-benzoxazepine
• 英文别名: 7-(2-methyl-3H-benzimidazol-5-yl)-4-(6-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)-3,5-dihydro-2H-1,4-benzoxazepine
• CAS: 1256945-99-9
• 化学式: C₂₅H₂₅N₅O
• 分子量: 411.506
• InChiKey: AFSKHCJTBIOWMI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  31
• 可旋转键数：
  2
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  66.9
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture
  申请人：Rice Kenneth D.

  公开号：US20140080810A1

  公开（公告）日：2014-03-20

  The invention is directed to Compounds of Formula I: (I) and pharmaceutically acceptable salts or solvates thereof, as well as methods of treating using the compounds, methods for screening for inhibitor compounds and methods for identifying treatment regimens.

  本发明涉及化合物I式：（I）及其药学上可接受的盐或溶剂化物，以及使用该化合物进行治疗的方法，筛选抑制剂化合物的方法和确定治疗方案的方法。
• BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES
  申请人：Exelixis, Inc.

  公开号：EP2432779A1

  公开（公告）日：2012-03-28
• BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE
  申请人：Exelixis, Inc.

  公开号：EP2640366A2

  公开（公告）日：2013-09-25
• US8648066B2
  申请人：——

  公开号：US8648066B2

  公开（公告）日：2014-02-11
• [EN] BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES<br/>[FR] INHIBITEURS DE PI3K/MTOR À BASE DE BENZOXAZÉPINES POUR LUTTER CONTRE LES MALADIES PROLIFÉRATIVES
  申请人：EXELIXIS INC

  公开号：WO2010135524A1

  公开（公告）日：2010-11-25

  The invention is directed to compounds of formula (I), and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds.